15 results on '"Moersdorf M"'
Search Results
2. Temporal variability of electromechanical-window negativity in patients with inherited long-QT syndrome or drug-induced QT prolongation: relation to torsades de pointes
- Author
-
Deissler, P, primary, Berkovitch, A, additional, Rahm, A K, additional, Sikking, M, additional, Moersdorf, M, additional, Sohns, C, additional, Rieder, M, additional, Nimani, S, additional, Odening, K E, additional, Sabbag, A, additional, Volders, P G A, additional, and Ter Bekke, R M A, additional
- Published
- 2024
- Full Text
- View/download PDF
3. Biotic interactions mediate patterns of herbivore diversity in the Arctic
- Author
-
Barrio, I. C., Bueno, C. G., Gartzia, M., Soininen, E. M., Christie, K. S., Speed, J. D. M., Ravolainen, V. T., Forbes, B. C., Gauthier, G., Horstkotte, T., Hoset, K. S., Høye, T. T., Jónsdóttir, I. S., Lévesque, E., Mörsdorf, M. A., Olofsson, J., Wookey, P. A., and Hik, D. S.
- Published
- 2016
4. Global maps of soil temperature
- Author
-
Lembrechts, J. J. (Jonas J.), van den Hoogen, J. (Johan), Aalto, J. (Juha), Ashcroft, M. B. (Michael B.), De Frenne, P. (Pieter), Kemppinen, J. (Julia), Kopecky, M. (Martin), Luoto, M. (Miska), Maclean, I. M. (Ilya M. D.), Crowther, T. W. (Thomas W.), Bailey, J. J. (Joseph J.), Haesen, S. (Stef), Klinges, D. H. (David H.), Niittynen, P. (Pekka), Scheffers, B. R. (Brett R.), Van Meerbeek, K. (Koenraad), Aartsma, P. (Peter), Abdalaze, O. (Otar), Abedi, M. (Mehdi), Aerts, R. (Rien), Ahmadian, N. (Negar), Ahrends, A. (Antje), Alatalo, J. M. (Juha M.), Alexander, J. M. (Jake M.), Allonsius, C. N. (Camille Nina), Altman, J. (Jan), Ammann, C. (Christof), Andres, C. (Christian), Andrews, C. (Christopher), Ardo, J. (Jonas), Arriga, N. (Nicola), Arzac, A. (Alberto), Aschero, V. (Valeria), Assis, R. L. (Rafael L.), Assmann, J. J. (Jakob Johann), Bader, M. Y. (Maaike Y.), Bahalkeh, K. (Khadijeh), Barancok, P. (Peter), Barrio, I. C. (Isabel C.), Barros, A. (Agustina), Barthel, M. (Matti), Basham, E. W. (Edmund W.), Bauters, M. (Marijn), Bazzichetto, M. (Manuele), Marchesini, L. B. (Luca Belelli), Bell, M. C. (Michael C.), Benavides, J. C. (Juan C.), Benito Alonso, J. L. (Jose Luis), Berauer, B. J. (Bernd J.), Bjerke, J. W. (Jarle W.), Bjork, R. G. (Robert G.), Bjorkman, M. P. (Mats P.), Bjornsdottir, K. (Katrin), Blonder, B. (Benjamin), Boeckx, P. (Pascal), Boike, J. (Julia), Bokhorst, S. (Stef), Brum, B. N. (Barbara N. S.), Bruna, J. (Josef), Buchmann, N. (Nina), Buysse, P. (Pauline), Camargo, J. L. (Jose Luis), Campoe, O. C. (Otavio C.), Candan, O. (Onur), Canessa, R. (Rafaella), Cannone, N. (Nicoletta), Carbognani, M. (Michele), Carnicer, J. (Jofre), Casanova-Katny, A. (Angelica), Cesarz, S. (Simone), Chojnicki, B. (Bogdan), Choler, P. (Philippe), Chown, S. L. (Steven L.), Cifuentes, E. F. (Edgar F.), Ciliak, M. (Marek), Contador, T. (Tamara), Convey, P. (Peter), Cooper, E. J. (Elisabeth J.), Cremonese, E. (Edoardo), Curasi, S. R. (Salvatore R.), Curtis, R. (Robin), Cutini, M. (Maurizio), Dahlberg, C. J. (C. Johan), Daskalova, G. N. (Gergana N.), Angel de Pablo, M. (Miguel), Della Chiesa, S. (Stefano), Dengler, J. (Juergen), Deronde, B. (Bart), Descombes, P. (Patrice), Di Cecco, V. (Valter), Di Musciano, M. (Michele), Dick, J. (Jan), Dimarco, R. D. (Romina D.), Dolezal, J. (Jiri), Dorrepaal, E. (Ellen), Dusek, J. (Jiri), Eisenhauer, N. (Nico), Eklundh, L. (Lars), Erickson, T. E. (Todd E.), Erschbamer, B. (Brigitta), Eugster, W. (Werner), Ewers, R. M. (Robert M.), Exton, D. A. (Dan A.), Fanin, N. (Nicolas), Fazlioglu, F. (Fatih), Feigenwinter, I. (Iris), Fenu, G. (Giuseppe), Ferlian, O. (Olga), Fernandez Calzado, M. R. (M. Rosa), Fernandez-Pascual, E. (Eduardo), Finckh, M. (Manfred), Higgens, R. F. (Rebecca Finger), Forte, T. G. (T'ai G. W.), Freeman, E. C. (Erika C.), Frei, E. R. (Esther R.), Fuentes-Lillo, E. (Eduardo), Garcia, R. A. (Rafael A.), Garcia, M. B. (Maria B.), Geron, C. (Charly), Gharun, M. (Mana), Ghosn, D. (Dany), Gigauri, K. (Khatuna), Gobin, A. (Anne), Goded, I. (Ignacio), Goeckede, M. (Mathias), Gottschall, F. (Felix), Goulding, K. (Keith), Govaert, S. (Sanne), Graae, B. J. (Bente Jessen), Greenwood, S. (Sarah), Greiser, C. (Caroline), Grelle, A. (Achim), Guenard, B. (Benoit), Guglielmin, M. (Mauro), Guillemot, J. (Joannes), Haase, P. (Peter), Haider, S. (Sylvia), Halbritter, A. H. (Aud H.), Hamid, M. (Maroof), Hammerle, A. (Albin), Hampe, A. (Arndt), Haugum, S. V. (Siri, V), Hederova, L. (Lucia), Heinesch, B. (Bernard), Helfter, C. (Carole), Hepenstrick, D. (Daniel), Herberich, M. (Maximiliane), Herbst, M. (Mathias), Hermanutz, L. (Luise), Hik, D. S. (David S.), Hoffren, R. (Raul), Homeier, J. (Juergen), Hörtnagl, L. (Lukas), Hoye, T. T. (Toke T.), Hrbacek, F. (Filip), Hylander, K. (Kristoffer), Iwata, H. (Hiroki), Jackowicz-Korczynski, M. A. (Marcin Antoni), Jactel, H. (Herve), Jarveoja, J. (Jarvi), Jastrzebowski, S. (Szymon), Jentsch, A. (Anke), Jimenez, J. J. (Juan J.), Jonsdottir, I. S. (Ingibjorg S.), Jucker, T. (Tommaso), Jump, A. S. (Alistair S.), Juszczak, R. (Radoslaw), Kanka, R. (Robert), Kaspar, V. (Vit), Kazakis, G. (George), Kelly, J. (Julia), Khuroo, A. A. (Anzar A.), Klemedtsson, L. (Leif), Klisz, M. (Marcin), Kljun, N. (Natascha), Knohl, A. (Alexander), Kobler, J. (Johannes), Kollar, J. (Jozef), Kotowska, M. M. (Martyna M.), Kovacs, B. (Bence), Kreyling, J. (Juergen), Lamprecht, A. (Andrea), Lang, S. I. (Simone, I), Larson, C. (Christian), Larson, K. (Keith), Laska, K. (Kamil), Maire, G. I. (Guerric Ie), Leihy, R. I. (Rachel, I), Lens, L. (Luc), Liljebladh, B. (Bengt), Lohila, A. (Annalea), Lorite, J. (Juan), Loubet, B. (Benjamin), Lynn, J. (Joshua), Macek, M. (Martin), Mackenzie, R. (Roy), Magliulo, E. (Enzo), Maier, R. (Regine), Malfasi, F. (Francesco), Malis, F. (Frantisek), Man, M. (Matej), Manca, G. (Giovanni), Manco, A. (Antonio), Manise, T. (Tanguy), Manolaki, P. (Paraskevi), Marciniak, F. (Felipe), Matula, R. (Radim), Clara Mazzolari, A. (Ana), Medinets, S. (Sergiy), Medinets, V. (Volodymyr), Meeussen, C. (Camille), Merinero, S. (Sonia), Guimaraes Mesquita, R. d. (Rita de Cassia), Meusburger, K. (Katrin), Meysman, F. J. (Filip J. R.), Michaletz, S. T. (Sean T.), Milbau, A. (Ann), Moiseev, D. (Dmitry), Moiseev, P. (Pavel), Mondoni, A. (Andrea), Monfries, R. (Ruth), Montagnani, L. (Leonardo), Moriana-Armendariz, M. (Mikel), di Cella, U. M. (Umberto Morra), Moersdorf, M. (Martin), Mosedale, J. R. (Jonathan R.), Muffler, L. (Lena), Munoz-Rojas, M. (Miriam), Myers, J. A. (Jonathan A.), Myers-Smith, I. H. (Isla H.), Nagy, L. (Laszlo), Nardino, M. (Marianna), Naujokaitis-Lewis, I. (Ilona), Newling, E. (Emily), Nicklas, L. (Lena), Niedrist, G. (Georg), Niessner, A. (Armin), Nilsson, M. B. (Mats B.), Normand, S. (Signe), Nosetto, M. D. (Marcelo D.), Nouvellon, Y. (Yann), Nunez, M. A. (Martin A.), Ogaya, R. (Roma), Ogee, J. (Jerome), Okello, J. (Joseph), Olejnik, J. (Janusz), Olesen, J. E. (Jorgen Eivind), Opedal, O. H. (Oystein H.), Orsenigo, S. (Simone), Palaj, A. (Andrej), Pampuch, T. (Timo), Panov, A. V. (Alexey V.), Pärtel, M. (Meelis), Pastor, A. (Ada), Pauchard, A. (Aníbal), Pauli, H. (Harald), Pavelka, M. (Marian), Pearse, W. D. (William D.), Peichl, M. (Matthias), Pellissier, L. (Loïc), Penczykowski, R. M. (Rachel M.), Penuelas, J. (Josep), Petit Bon, M. (Matteo), Petraglia, A. (Alessandro), Phartyal, S. S. (Shyam S.), Phoenix, G. K. (Gareth K.), Pio, C. (Casimiro), Pitacco, A. (Andrea), Pitteloud, C. (Camille), Plichta, R. (Roman), Porro, F. (Francesco), Portillo-Estrada, M. (Miguel), Poulenard, J. (Jérôme), Poyatos, R. (Rafael), Prokushkin, A. S. (Anatoly S.), Puchalka, R. (Radoslaw), Pușcaș, M. (Mihai), Radujković, D. (Dajana), Randall, K. (Krystal), Ratier Backes, A. (Amanda), Remmele, S. (Sabine), Remmers, W. (Wolfram), Renault, D. (David), Risch, A. C. (Anita C.), Rixen, C. (Christian), Robinson, S. A. (Sharon A.), Robroek, B. J. (Bjorn J. M.), Rocha, A. V. (Adrian V.), Rossi, C. (Christian), Rossi, G. (Graziano), Roupsard, O. (Olivier), Rubtsov, A. V. (Alexey V.), Saccone, P. (Patrick), Sagot, C. (Clotilde), Sallo Bravo, J. (Jhonatan), Santos, C. C. (Cinthya C.), Sarneel, J. M. (Judith M.), Scharnweber, T. (Tobias), Schmeddes, J. (Jonas), Schmidt, M. (Marius), Scholten, T. (Thomas), Schuchardt, M. (Max), Schwartz, N. (Naomi), Scott, T. (Tony), Seeber, J. (Julia), Segalin De Andrade, A. C. (Ana Cristina), Seipel, T. (Tim), Semenchuk, P. (Philipp), Senior, R. A. (Rebecca A.), Serra-Diaz, J. M. (Josep M.), Sewerniak, P. (Piotr), Shekhar, A. (Ankit), Sidenko, N. V. (Nikita V.), Siebicke, L. (Lukas), Siegwart Collier, L. (Laura), Simpson, E. (Elizabeth), Siqueira, D. P. (David P.), Sitková, Z. (Zuzana), Six, J. (Johan), Smiljanic, M. (Marko), Smith, S. W. (Stuart W.), Smith-Tripp, S. (Sarah), Somers, B. (Ben), Sørensen, M. V. (Mia Vedel), Souza, J. J. (José João L. L.), Souza, B. I. (Bartolomeu Israel), Dias, A. S. (Arildo Souza), Spasojevic, M. J. (Marko J.), Speed, J. D. (James D. M.), Spicher, F. (Fabien), Stanisci, A. (Angela), Steinbauer, K. (Klaus), Steinbrecher, R. (Rainer), Steinwandter, M. (Michael), Stemkovski, M. (Michael), Stephan, J. G. (Jörg G.), Stiegler, C. (Christian), Stoll, S. (Stefan), Svátek, M. (Martin), Svoboda, M. (Miroslav), Tagesson, T. (Torbern), Tanentzap, A. J. (Andrew J.), Tanneberger, F. (Franziska), Theurillat, J.-P. (Jean-Paul), Thomas, H. J. (Haydn J. D.), Thomas, A. D. (Andrew D.), Tielbörger, K. (Katja), Tomaselli, M. (Marcello), Treier, U. A. (Urs Albert), Trouillier, M. (Mario), Turtureanu, P. D. (Pavel Dan), Tutton, R. (Rosamond), Tyystjärvi, V. A. (Vilna A.), Ueyama, M. (Masahito), Ujházy, K. (Karol), Ujházyová, M. (Mariana), Uogintas, D. (Domas), Urban, A. V. (Anastasiya V.), Urban, J. (Josef), Urbaniak, M. (Marek), Ursu, T.-M. (Tudor-Mihai), Vaccari, F. P. (Francesco Primo), Van De Vondel, S. (Stijn), Van Den Brink, L. (Liesbeth), Van Geel, M. (Maarten), Vandvik, V. (Vigdis), Vangansbeke, P. (Pieter), Varlagin, A. (Andrej), Veen, G. F. (G. F.), Veenendaal, E. (Elmar), Venn, S. E. (Susanna E.), Verbeeck, H. (Hans), Verbrugggen, E. (Erik), Verheijen, F. G. (Frank G. A.), Villar, L. (Luis), Vitale, L. (Luca), Vittoz, P. (Pascal), Vives-Ingla, M. (Maria), Von Oppen, J. (Jonathan), Walz, J. (Josefine), Wang, R. (Runxi), Wang, Y. (Yifeng), Way, R. G. (Robert G.), Wedegärtner, R. E. (Ronja E. M.), Weigel, R. (Robert), Wild, J. (Jan), Wilkinson, M. (Matthew), Wilmking, M. (Martin), Wingate, L. (Lisa), Winkler, M. (Manuela), Wipf, S. (Sonja), Wohlfahrt, G. (Georg), Xenakis, G. (Georgios), Yang, Y. (Yan), Yu, Z. (Zicheng), Yu, K. (Kailiang), Zellweger, F. (Florian), Zhang, J. (Jian), Zhang, Z. (Zhaochen), Zhao, P. (Peng), Ziemblińska, K. (Klaudia), Zimmermann, R. (Reiner), Zong, S. (Shengwei), Zyryanov, V. I. (Viacheslav I.), Nijs, I. (Ivan), Lenoir, J. (Jonathan), Lembrechts, J. J. (Jonas J.), van den Hoogen, J. (Johan), Aalto, J. (Juha), Ashcroft, M. B. (Michael B.), De Frenne, P. (Pieter), Kemppinen, J. (Julia), Kopecky, M. (Martin), Luoto, M. (Miska), Maclean, I. M. (Ilya M. D.), Crowther, T. W. (Thomas W.), Bailey, J. J. (Joseph J.), Haesen, S. (Stef), Klinges, D. H. (David H.), Niittynen, P. (Pekka), Scheffers, B. R. (Brett R.), Van Meerbeek, K. (Koenraad), Aartsma, P. (Peter), Abdalaze, O. (Otar), Abedi, M. (Mehdi), Aerts, R. (Rien), Ahmadian, N. (Negar), Ahrends, A. (Antje), Alatalo, J. M. (Juha M.), Alexander, J. M. (Jake M.), Allonsius, C. N. (Camille Nina), Altman, J. (Jan), Ammann, C. (Christof), Andres, C. (Christian), Andrews, C. (Christopher), Ardo, J. (Jonas), Arriga, N. (Nicola), Arzac, A. (Alberto), Aschero, V. (Valeria), Assis, R. L. (Rafael L.), Assmann, J. J. (Jakob Johann), Bader, M. Y. (Maaike Y.), Bahalkeh, K. (Khadijeh), Barancok, P. (Peter), Barrio, I. C. (Isabel C.), Barros, A. (Agustina), Barthel, M. (Matti), Basham, E. W. (Edmund W.), Bauters, M. (Marijn), Bazzichetto, M. (Manuele), Marchesini, L. B. (Luca Belelli), Bell, M. C. (Michael C.), Benavides, J. C. (Juan C.), Benito Alonso, J. L. (Jose Luis), Berauer, B. J. (Bernd J.), Bjerke, J. W. (Jarle W.), Bjork, R. G. (Robert G.), Bjorkman, M. P. (Mats P.), Bjornsdottir, K. (Katrin), Blonder, B. (Benjamin), Boeckx, P. (Pascal), Boike, J. (Julia), Bokhorst, S. (Stef), Brum, B. N. (Barbara N. S.), Bruna, J. (Josef), Buchmann, N. (Nina), Buysse, P. (Pauline), Camargo, J. L. (Jose Luis), Campoe, O. C. (Otavio C.), Candan, O. (Onur), Canessa, R. (Rafaella), Cannone, N. (Nicoletta), Carbognani, M. (Michele), Carnicer, J. (Jofre), Casanova-Katny, A. (Angelica), Cesarz, S. (Simone), Chojnicki, B. (Bogdan), Choler, P. (Philippe), Chown, S. L. (Steven L.), Cifuentes, E. F. (Edgar F.), Ciliak, M. (Marek), Contador, T. (Tamara), Convey, P. (Peter), Cooper, E. J. (Elisabeth J.), Cremonese, E. (Edoardo), Curasi, S. R. (Salvatore R.), Curtis, R. (Robin), Cutini, M. (Maurizio), Dahlberg, C. J. (C. Johan), Daskalova, G. N. (Gergana N.), Angel de Pablo, M. (Miguel), Della Chiesa, S. (Stefano), Dengler, J. (Juergen), Deronde, B. (Bart), Descombes, P. (Patrice), Di Cecco, V. (Valter), Di Musciano, M. (Michele), Dick, J. (Jan), Dimarco, R. D. (Romina D.), Dolezal, J. (Jiri), Dorrepaal, E. (Ellen), Dusek, J. (Jiri), Eisenhauer, N. (Nico), Eklundh, L. (Lars), Erickson, T. E. (Todd E.), Erschbamer, B. (Brigitta), Eugster, W. (Werner), Ewers, R. M. (Robert M.), Exton, D. A. (Dan A.), Fanin, N. (Nicolas), Fazlioglu, F. (Fatih), Feigenwinter, I. (Iris), Fenu, G. (Giuseppe), Ferlian, O. (Olga), Fernandez Calzado, M. R. (M. Rosa), Fernandez-Pascual, E. (Eduardo), Finckh, M. (Manfred), Higgens, R. F. (Rebecca Finger), Forte, T. G. (T'ai G. W.), Freeman, E. C. (Erika C.), Frei, E. R. (Esther R.), Fuentes-Lillo, E. (Eduardo), Garcia, R. A. (Rafael A.), Garcia, M. B. (Maria B.), Geron, C. (Charly), Gharun, M. (Mana), Ghosn, D. (Dany), Gigauri, K. (Khatuna), Gobin, A. (Anne), Goded, I. (Ignacio), Goeckede, M. (Mathias), Gottschall, F. (Felix), Goulding, K. (Keith), Govaert, S. (Sanne), Graae, B. J. (Bente Jessen), Greenwood, S. (Sarah), Greiser, C. (Caroline), Grelle, A. (Achim), Guenard, B. (Benoit), Guglielmin, M. (Mauro), Guillemot, J. (Joannes), Haase, P. (Peter), Haider, S. (Sylvia), Halbritter, A. H. (Aud H.), Hamid, M. (Maroof), Hammerle, A. (Albin), Hampe, A. (Arndt), Haugum, S. V. (Siri, V), Hederova, L. (Lucia), Heinesch, B. (Bernard), Helfter, C. (Carole), Hepenstrick, D. (Daniel), Herberich, M. (Maximiliane), Herbst, M. (Mathias), Hermanutz, L. (Luise), Hik, D. S. (David S.), Hoffren, R. (Raul), Homeier, J. (Juergen), Hörtnagl, L. (Lukas), Hoye, T. T. (Toke T.), Hrbacek, F. (Filip), Hylander, K. (Kristoffer), Iwata, H. (Hiroki), Jackowicz-Korczynski, M. A. (Marcin Antoni), Jactel, H. (Herve), Jarveoja, J. (Jarvi), Jastrzebowski, S. (Szymon), Jentsch, A. (Anke), Jimenez, J. J. (Juan J.), Jonsdottir, I. S. (Ingibjorg S.), Jucker, T. (Tommaso), Jump, A. S. (Alistair S.), Juszczak, R. (Radoslaw), Kanka, R. (Robert), Kaspar, V. (Vit), Kazakis, G. (George), Kelly, J. (Julia), Khuroo, A. A. (Anzar A.), Klemedtsson, L. (Leif), Klisz, M. (Marcin), Kljun, N. (Natascha), Knohl, A. (Alexander), Kobler, J. (Johannes), Kollar, J. (Jozef), Kotowska, M. M. (Martyna M.), Kovacs, B. (Bence), Kreyling, J. (Juergen), Lamprecht, A. (Andrea), Lang, S. I. (Simone, I), Larson, C. (Christian), Larson, K. (Keith), Laska, K. (Kamil), Maire, G. I. (Guerric Ie), Leihy, R. I. (Rachel, I), Lens, L. (Luc), Liljebladh, B. (Bengt), Lohila, A. (Annalea), Lorite, J. (Juan), Loubet, B. (Benjamin), Lynn, J. (Joshua), Macek, M. (Martin), Mackenzie, R. (Roy), Magliulo, E. (Enzo), Maier, R. (Regine), Malfasi, F. (Francesco), Malis, F. (Frantisek), Man, M. (Matej), Manca, G. (Giovanni), Manco, A. (Antonio), Manise, T. (Tanguy), Manolaki, P. (Paraskevi), Marciniak, F. (Felipe), Matula, R. (Radim), Clara Mazzolari, A. (Ana), Medinets, S. (Sergiy), Medinets, V. (Volodymyr), Meeussen, C. (Camille), Merinero, S. (Sonia), Guimaraes Mesquita, R. d. (Rita de Cassia), Meusburger, K. (Katrin), Meysman, F. J. (Filip J. R.), Michaletz, S. T. (Sean T.), Milbau, A. (Ann), Moiseev, D. (Dmitry), Moiseev, P. (Pavel), Mondoni, A. (Andrea), Monfries, R. (Ruth), Montagnani, L. (Leonardo), Moriana-Armendariz, M. (Mikel), di Cella, U. M. (Umberto Morra), Moersdorf, M. (Martin), Mosedale, J. R. (Jonathan R.), Muffler, L. (Lena), Munoz-Rojas, M. (Miriam), Myers, J. A. (Jonathan A.), Myers-Smith, I. H. (Isla H.), Nagy, L. (Laszlo), Nardino, M. (Marianna), Naujokaitis-Lewis, I. (Ilona), Newling, E. (Emily), Nicklas, L. (Lena), Niedrist, G. (Georg), Niessner, A. (Armin), Nilsson, M. B. (Mats B.), Normand, S. (Signe), Nosetto, M. D. (Marcelo D.), Nouvellon, Y. (Yann), Nunez, M. A. (Martin A.), Ogaya, R. (Roma), Ogee, J. (Jerome), Okello, J. (Joseph), Olejnik, J. (Janusz), Olesen, J. E. (Jorgen Eivind), Opedal, O. H. (Oystein H.), Orsenigo, S. (Simone), Palaj, A. (Andrej), Pampuch, T. (Timo), Panov, A. V. (Alexey V.), Pärtel, M. (Meelis), Pastor, A. (Ada), Pauchard, A. (Aníbal), Pauli, H. (Harald), Pavelka, M. (Marian), Pearse, W. D. (William D.), Peichl, M. (Matthias), Pellissier, L. (Loïc), Penczykowski, R. M. (Rachel M.), Penuelas, J. (Josep), Petit Bon, M. (Matteo), Petraglia, A. (Alessandro), Phartyal, S. S. (Shyam S.), Phoenix, G. K. (Gareth K.), Pio, C. (Casimiro), Pitacco, A. (Andrea), Pitteloud, C. (Camille), Plichta, R. (Roman), Porro, F. (Francesco), Portillo-Estrada, M. (Miguel), Poulenard, J. (Jérôme), Poyatos, R. (Rafael), Prokushkin, A. S. (Anatoly S.), Puchalka, R. (Radoslaw), Pușcaș, M. (Mihai), Radujković, D. (Dajana), Randall, K. (Krystal), Ratier Backes, A. (Amanda), Remmele, S. (Sabine), Remmers, W. (Wolfram), Renault, D. (David), Risch, A. C. (Anita C.), Rixen, C. (Christian), Robinson, S. A. (Sharon A.), Robroek, B. J. (Bjorn J. M.), Rocha, A. V. (Adrian V.), Rossi, C. (Christian), Rossi, G. (Graziano), Roupsard, O. (Olivier), Rubtsov, A. V. (Alexey V.), Saccone, P. (Patrick), Sagot, C. (Clotilde), Sallo Bravo, J. (Jhonatan), Santos, C. C. (Cinthya C.), Sarneel, J. M. (Judith M.), Scharnweber, T. (Tobias), Schmeddes, J. (Jonas), Schmidt, M. (Marius), Scholten, T. (Thomas), Schuchardt, M. (Max), Schwartz, N. (Naomi), Scott, T. (Tony), Seeber, J. (Julia), Segalin De Andrade, A. C. (Ana Cristina), Seipel, T. (Tim), Semenchuk, P. (Philipp), Senior, R. A. (Rebecca A.), Serra-Diaz, J. M. (Josep M.), Sewerniak, P. (Piotr), Shekhar, A. (Ankit), Sidenko, N. V. (Nikita V.), Siebicke, L. (Lukas), Siegwart Collier, L. (Laura), Simpson, E. (Elizabeth), Siqueira, D. P. (David P.), Sitková, Z. (Zuzana), Six, J. (Johan), Smiljanic, M. (Marko), Smith, S. W. (Stuart W.), Smith-Tripp, S. (Sarah), Somers, B. (Ben), Sørensen, M. V. (Mia Vedel), Souza, J. J. (José João L. L.), Souza, B. I. (Bartolomeu Israel), Dias, A. S. (Arildo Souza), Spasojevic, M. J. (Marko J.), Speed, J. D. (James D. M.), Spicher, F. (Fabien), Stanisci, A. (Angela), Steinbauer, K. (Klaus), Steinbrecher, R. (Rainer), Steinwandter, M. (Michael), Stemkovski, M. (Michael), Stephan, J. G. (Jörg G.), Stiegler, C. (Christian), Stoll, S. (Stefan), Svátek, M. (Martin), Svoboda, M. (Miroslav), Tagesson, T. (Torbern), Tanentzap, A. J. (Andrew J.), Tanneberger, F. (Franziska), Theurillat, J.-P. (Jean-Paul), Thomas, H. J. (Haydn J. D.), Thomas, A. D. (Andrew D.), Tielbörger, K. (Katja), Tomaselli, M. (Marcello), Treier, U. A. (Urs Albert), Trouillier, M. (Mario), Turtureanu, P. D. (Pavel Dan), Tutton, R. (Rosamond), Tyystjärvi, V. A. (Vilna A.), Ueyama, M. (Masahito), Ujházy, K. (Karol), Ujházyová, M. (Mariana), Uogintas, D. (Domas), Urban, A. V. (Anastasiya V.), Urban, J. (Josef), Urbaniak, M. (Marek), Ursu, T.-M. (Tudor-Mihai), Vaccari, F. P. (Francesco Primo), Van De Vondel, S. (Stijn), Van Den Brink, L. (Liesbeth), Van Geel, M. (Maarten), Vandvik, V. (Vigdis), Vangansbeke, P. (Pieter), Varlagin, A. (Andrej), Veen, G. F. (G. F.), Veenendaal, E. (Elmar), Venn, S. E. (Susanna E.), Verbeeck, H. (Hans), Verbrugggen, E. (Erik), Verheijen, F. G. (Frank G. A.), Villar, L. (Luis), Vitale, L. (Luca), Vittoz, P. (Pascal), Vives-Ingla, M. (Maria), Von Oppen, J. (Jonathan), Walz, J. (Josefine), Wang, R. (Runxi), Wang, Y. (Yifeng), Way, R. G. (Robert G.), Wedegärtner, R. E. (Ronja E. M.), Weigel, R. (Robert), Wild, J. (Jan), Wilkinson, M. (Matthew), Wilmking, M. (Martin), Wingate, L. (Lisa), Winkler, M. (Manuela), Wipf, S. (Sonja), Wohlfahrt, G. (Georg), Xenakis, G. (Georgios), Yang, Y. (Yan), Yu, Z. (Zicheng), Yu, K. (Kailiang), Zellweger, F. (Florian), Zhang, J. (Jian), Zhang, Z. (Zhaochen), Zhao, P. (Peng), Ziemblińska, K. (Klaudia), Zimmermann, R. (Reiner), Zong, S. (Shengwei), Zyryanov, V. I. (Viacheslav I.), Nijs, I. (Ivan), and Lenoir, J. (Jonathan)
- Abstract
Research in global change ecology relies heavily on global climatic grids derived from estimates of air temperature in open areas at around 2 m above the ground. These climatic grids do not reflect conditions below vegetation canopies and near the ground surface, where critical ecosystem functions occur and most terrestrial species reside. Here, we provide global maps of soil temperature and bioclimatic variables at a 1-km² resolution for 0‐5 and 5‐15 cm soil depth. These maps were created by calculating the difference (i.e. offset) between in situ soil temperature measurements, based on time series from over 1200 1‐km² pixels (summarized from 8519 unique temperature sensors) across all the world’s major terrestrial biomes, and coarse-grained air temperature estimates from ERA5-Land (an atmospheric reanalysis by the European Centre for Medium-Range Weather Forecasts). We show that mean annual soil temperature differs markedly from the corresponding gridded air temperature, by up to 10° degrees C (mean = 3.0 +/‐ 2.1° degrees C), with substantial variation across biomes and seasons. Over the year, soils in cold and/or dry biomes are substantially warmer (+3.6 +/‐2.3° degrees C) than gridded air temperature, whereas soils in warm and humid environments are on average slightly cooler (‐0.7 +/‐ 2.3° degrees C). The observed substantial and biome-specific offsets emphasize that the projected impacts of climate and climate change on near-surface biodiversity and ecosystem functioning are inaccurately assessed when air rather than soil temperature is used, especially in cold environments. The global soil-related bioclimatic variables provided here are an important step forward for any application in ecology and related disciplines. Nevertheless, we highlight the need to fill remaining geographic gaps by collecting more in situ measurements of microclimate conditions to further enhance the spatiotemporal resolution of global soil temperature products for ecological
- Published
- 2022
5. Paraplegia after sclerotherapy of varicose leg veins
- Author
-
Brenner, E., primary, Prinz, N., primary, Glowacki, P., primary, Moersdorf, M., primary, Maschke, M., primary, and Frings, N., additional
- Published
- 2017
- Full Text
- View/download PDF
6. Otorrhagia from the 'Aberrant Internal Carotid' Artery in the Middle Ear
- Author
-
Mendel L, Lysdahl M, Moersdorf M, and Michael Söderman
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Ascending pharyngeal artery ,medicine.disease ,03 medical and health sciences ,Skull ,0302 clinical medicine ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Agenesis ,medicine.artery ,Temporal bone ,Biopsy ,Middle ear ,medicine ,Radiology ,Internal carotid artery ,030223 otorhinolaryngology ,business ,Cerebral angiography - Abstract
Agenesis of the cervical portion of the internal carotid artery (ICA) may result in blood supply to the ipsilateral cerebral hemisphere being provided by an enlarged inferior tympanic branch of the ascending pharyngeal artery. This enlarged vessel, passing through Jacobson's canal and anastomosing with the likewise enlarged caroticotympanic branch of the ICA in front of the promontorium, may simulate a middle ear mass. We present five patients with this unusual anatomical variant, three of which underwent biopsy of what was believed to be a middle ear tumour. One patient experienced rupture of an arterial aneurysm in the middle ear successfully treated with endovascular application of detachable platinum coils. It is mandatory for ENT-surgeons and radiologists who perform head-and-neck examinations to recognize this anatomical variant, not mistaking it for a tumour, since biopsy of a large artery supplying the brain may have disastrous consequences. In patients with otorrhagia, an arterial aneurysm must be considered as a possible source of bleeding, in some cases amenable for treatment with an endovascular technique. The diagnosis of “aberrant internal carotid artery” is usually made with CT of the temporal bone or MR of the skull base. Cerebral angiography is in most cases not necessary, unless an endovascular procedure is planned.
- Published
- 1997
7. Paraplegia after sclerotherapy of varicose leg veins
- Author
-
Frings, N., Brenner, E., Prinz, N., Glowacki, P., Moersdorf, M., and Maschke, M.
- Published
- 2017
- Full Text
- View/download PDF
8. Otorrhagia from the “Aberrant Internal Carotid” Artery in the Middle Ear
- Author
-
Söderman, M., primary, Moersdorf, M., additional, Lysdahl, M., additional, and Mendel, L., additional
- Published
- 1997
- Full Text
- View/download PDF
9. Quantified Partial Embolisation in a Vein of Galen Malformation with Congestive Cardiac Failure
- Author
-
Moersdorf, M., primary and Lasjaunias, P., additional
- Published
- 1996
- Full Text
- View/download PDF
10. Preventive catheter ablation for ventricular arrhythmias in patients with end-stage heart failure referred for heart transplantation evaluation: Rationale for and design of the CASTLE-VT trial.
- Author
-
Sohns C, Fink T, Crijns HJGM, Costard-Jaeckle A, Marrouche NF, Sossalla S, Schramm R, El Hamriti M, Moersdorf M, Didenko M, Braun M, Sciacca V, Konietschke F, Rudolph V, Gummert J, Tijssen JGP, and Sommer P
- Abstract
Aims: Timely referrals for transplantation and left ventricular assist device (LVAD) play a key role in favourable outcomes in patients with advanced heart failure (HF). Cardiovascular mortality, driven by sudden cardiac death, is the main reason for dying while waiting for heart transplantation (HTx). The purpose of the Preventive Catheter Ablation for ventricular arrhythmiaS in patients with end-sTage heart faiLure rEferred for heart transplantation eValuaTion (CASTLE-VT) trial is to test the hypothesis that prophylactic catheter ablation of arrhythmogenic ventricular scar tissue will reduce mortality, need for LVAD implantation, and urgent HTx in patients with end-stage HF related to ischaemic cardiomyopathy (ICM)., Methods: CASTLE-VT is a randomized evaluation of prophylactic ablative treatment of arrhythmogenic ventricular scar in patients referred for HTx evaluation and diagnosed with ICM. Ablation will be performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary endpoint is the composite of all-cause mortality, worsening of HF requiring prioritized transplantation or LVAD implantation. The main secondary study endpoints are all-cause mortality, cardiovascular mortality, incidence of implantable cardioverter-defibrillator (ICD) therapy, hospitalizations, quality of life, time to first ICD therapy, number of device-detected ventricular tachycardia/ventricular fibrillation episodes, left ventricular function, and exercise tolerance. CASTLE-VT will randomize 160 patients with a follow-up period of 2 years., Conclusion: CASTLE-VT will determine whether prophylactic catheter ablation of arrhythmogenic ventricular scar tissue reduces mortality in patients with end-stage HF who are referred for HTx evaluation., (© 2024 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.)
- Published
- 2024
- Full Text
- View/download PDF
11. Effects of atrial fibrillation ablation on arrhythmia burden and ventricular function in end-stage heart failure: Lessons from CASTLE-HTx.
- Author
-
Sciacca V, Sohns C, Crijns HJGM, Marrouche NF, Schramm R, Moersdorf M, Fink T, Bergau L, Hindricks G, Dagres N, Sossalla S, Costard-Jaeckle A, Fox H, El Hamriti M, Konietschke F, Rudolph V, Gummert J, Tijssen JGP, and Sommer P
- Abstract
Aims: The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF). Herein we describe the effects of catheter ablation on AF burden, arrhythmia recurrences, and ventricular function in end-stage HF., Methods and Results: The CASTLE-HTx protocol randomized 194 patients in end-stage HF with AF to catheter ablation and medical therapy or medical therapy alone. AF burden, left ventricular ejection fraction (LVEF), and type of AF were assessed at baseline and at each follow-up visit. Overall, 97 patients received ablation; 66 patients (68%) underwent pulmonary vein isolation (PVI) and 31 patients (32%) were treated with PVI and additional ablation. Electroanatomic mapping showed the extent of left atrial low voltage (cardiomyopathy) >10% in 31 (31.9%) patients. At 12 months post-ablation, persistent AF was present in 31/89 patients (34.8%), which was significantly less frequent compared to baseline (p = 0.0001). Median AF burden reduction was 36.3 (interquartile range 13.6-63.3) percentage points at 12 months and LVEF improved from 29.2 ± 6.2% to 39.1 ± 8.3% (p < 0.001) following ablation. AF burden reduction <50% was significantly associated with LVEF improvement ≥5% at 12 months after ablation (p = 0.017)., Conclusion: Atrial fibrillation ablation in end-stage HF leads to a substantial decrease in AF burden, a regression from persistent to paroxysmal AF and notably improved LVEF. Favourable ablation outcomes were observed in patients regardless of the presence or absence of signs indicating left atrial cardiomyopathy., (© 2024 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.)
- Published
- 2024
- Full Text
- View/download PDF
12. Reply to the Editor - Atrial fibrillation and heart failure: To build a CASTLE you need a solid foundation.
- Author
-
Moersdorf M, Tijssen JGP, Sommer P, and Sohns C
- Subjects
- Humans, Atrial Fibrillation physiopathology, Atrial Fibrillation complications, Heart Failure physiopathology
- Abstract
Competing Interests: Disclosures The authors have no conflicts of interest to disclose.
- Published
- 2024
- Full Text
- View/download PDF
13. Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation: Two-year Follow-up of the CASTLE-HTx Trial.
- Author
-
Sohns C, Moersdorf M, Marrouche NF, Bergau L, Costard-Jaeckle A, Crijns HJGM, Fox H, Hindricks G, Dagres N, Sossalla S, Schramm R, Fink T, El Hamriti M, Sciacca V, Didenko M, Konietschke F, Rudolph V, Gummert J, Tijssen JGP, and Sommer P
- Published
- 2024
- Full Text
- View/download PDF
14. Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation: Insights from CASTLE-HTx.
- Author
-
Moersdorf M, Tijssen JGP, Marrouche NF, Crijns HJGM, Costard-Jaeckle A, Bergau L, Hindricks G, Dagres N, Sossalla S, Schramm R, Fox H, Fink T, El Hamriti M, Sciacca V, Konietschke F, Rudolph V, Gummert J, Sommer P, and Sohns C
- Subjects
- Humans, Male, Female, Middle Aged, Prognosis, Stroke Volume physiology, Heart Transplantation, Risk Factors, Aged, Follow-Up Studies, Treatment Outcome, Ventricular Function, Left physiology, Survival Rate trends, Atrial Fibrillation surgery, Atrial Fibrillation physiopathology, Atrial Fibrillation complications, Heart Failure physiopathology, Heart Failure complications, Catheter Ablation methods
- Abstract
Background: The CASTLE-HTx trial demonstrated the benefit of atrial fibrillation (AF) ablation compared with medical therapy in decreasing mortality, need for left ventricular assist device implantation, or heart transplantation (HTx) in patients with end-stage heart failure (HF)., Objective: This analysis aimed to identify risk factors related to adverse outcomes in patients with end-stage HF and to assess the impact of ablation., Methods: The CASTLE-HTx protocol randomized 194 patients with end-stage HF and AF to ablation vs medical therapy. We identified left ventricular ejection fraction <30%, New York Heart Association class ≥III, and AF burden >50% as predictors for the primary end point. The CASTLE-HTx risk score assigned weights to these risk factors. Patients with a risk score ≥3 were identified as high risk., Results: The patients were assigned to low-risk (89 [45.9%]) and high-risk (105 [54.1%]) groups. After a median follow-up of 18 months, a primary end point event occurred in 6 and 31 patients of the low- and high-risk groups (hazard ratio, 4.98; 95% confidence interval, 2.08-11.9). The incidence rate (IR) difference between ablation and medical therapy was much larger in high-risk patients (8/49 [IR, 11.4] vs 23/56 [IR, 36.1]) compared with low-risk patients (2/48 [IR, 2.6] vs 4/41 [IR, 6.3]). The IR difference for ablation was significantly higher in high-risk patients (24.69) compared with low-risk patients (3.70)., Conclusion: The absolute benefit of ablation is more pronounced in high-risk patients, but low-risk patients may also benefit. The CASTLE-HTx risk score identifies patients with end-stage HF who will particularly benefit from ablation., Competing Interests: Disclosures Dr Sohns received research support and lecture fees from Medtronic, Abbott, Boston Scientific, and Biosense Webster; is a consultant for Medtronic, Boston Scientific, and Biosense Webster; has received grant support from the Else Kröner-Fresenius-Stiftung and Deutsche Herzstiftung. Dr Sommer is member of the Advisory Board for Abbott, Biosense Webster, Boston Scientific, and Medtronic. Dr Crijns reports support from The Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation, CVON 2014-9: reappraisal of atrial fibrillation: interaction between hypercoagulability, electrical remodelling, and vascular destabilization in the progression of AF (RACE V), outside this work. Dr Sossalla received speaker fees from AstraZeneca and Boehringer Ingelheim. Dr Marrouche has received grant support and consulting fees from Abbott, Wavelet Health, Medtronic, Vytronus, Biosense Webster, Boston Scientific, GE HealthCare, and Siemens; has received consulting fees from Preventice; and holds equity in Marrek and Cardiac Design. Dr Rudolph has received grant support from Abbott Vascular and Edwards Lifesciences. All other authors have nothing to declare., (Copyright © 2024 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
- Author
-
Sohns C, Fox H, Marrouche NF, Crijns HJGM, Costard-Jaeckle A, Bergau L, Hindricks G, Dagres N, Sossalla S, Schramm R, Fink T, El Hamriti M, Moersdorf M, Sciacca V, Konietschke F, Rudolph V, Gummert J, Tijssen JGP, and Sommer P
- Subjects
- Humans, Anti-Arrhythmia Agents therapeutic use, Germany, Heart Transplantation, Heart-Assist Devices, Referral and Consultation, Treatment Outcome, Atrial Fibrillation complications, Atrial Fibrillation surgery, Catheter Ablation adverse effects, Catheter Ablation methods, Heart Failure complications, Heart Failure surgery
- Abstract
Background: The role of catheter ablation in patients with symptomatic atrial fibrillation and end-stage heart failure is unknown., Methods: We conducted a single-center, open-label trial in Germany that involved patients with symptomatic atrial fibrillation and end-stage heart failure who were referred for heart transplantation evaluation. Patients were assigned to receive catheter ablation and guideline-directed medical therapy or medical therapy alone. The primary end point was a composite of death from any cause, implantation of a left ventricular assist device, or urgent heart transplantation., Results: A total of 97 patients were assigned to the ablation group and 97 to the medical-therapy group. The trial was stopped for efficacy by the data and safety monitoring board 1 year after randomization was completed. Catheter ablation was performed in 81 of 97 patients (84%) in the ablation group and in 16 of 97 patients (16%) in the medical-therapy group. After a median follow-up of 18.0 months (interquartile range, 14.6 to 22.6), a primary end-point event had occurred in 8 patients (8%) in the ablation group and in 29 patients (30%) in the medical-therapy group (hazard ratio, 0.24; 95% confidence interval [CI], 0.11 to 0.52; P<0.001). Death from any cause occurred in 6 patients (6%) in the ablation group and in 19 patients (20%) in the medical-therapy group (hazard ratio, 0.29; 95% CI, 0.12 to 0.72). Procedure-related complications occurred in 3 patients in the ablation group and in 1 patient in the medical-therapy group., Conclusions: Among patients with atrial fibrillation and end-stage heart failure, the combination of catheter ablation and guideline-directed medical therapy was associated with a lower likelihood of a composite of death from any cause, implantation of a left ventricular assist device, or urgent heart transplantation than medical therapy alone. (Funded by Else Kröner-Fresenius-Stiftung; CASTLE-HTx ClinicalTrials.gov number, NCT04649801.)., (Copyright © 2023 Massachusetts Medical Society.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.